Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/17/2011CN101785773B Use of metal supermolecular compound in preparation of medicament for treating alzheimer's disease
08/17/2011CN101780094B Slow-release preparation of cucurbitacin
08/17/2011CN101780089B Irbesartan hydrochlorothiazide capsule and preparation method thereof
08/17/2011CN101766713B Anti-allergic traditional Chinese medicine preparation and preparation method thereof
08/17/2011CN101756993B Medical composition for losing weight or treating metabolic syndromes
08/17/2011CN101732452B Cleaning tablet of oral cavity and preparation method thereof
08/17/2011CN101732248B Metoprolol tartrate injection and preparation method thereof
08/17/2011CN101708253B Prickly heat powder
08/17/2011CN101708240B Heard-brain benefiting dropping pills and method for preparing same
08/17/2011CN101703753B Medicinal composition powders or granules for treating whitevein and preparation method thereof
08/17/2011CN101703723B Drug-breaking medicine and preparation method thereof
08/17/2011CN101703657B External preparation for treating verruca vulgaris
08/17/2011CN101703604B Medicament for treating dermatophytosis
08/17/2011CN101703603B External-use ointment for treating empyrosis and preparation method thereof
08/17/2011CN101693711B 3-(1-piperazinyl)-1,2-benzisothiazole derivative as well as synthesizing method and application thereof
08/17/2011CN101693034B Diffractive-ring mangiferin A in mango leaves and new application of mango leaf extractives containing diffractive-ring mangiferin A
08/17/2011CN101670019B Complex preparation having radiation-resisting and eyesight-protecting functions
08/17/2011CN101665481B Extraction method of eriosema chinense isoflavoid compound
08/17/2011CN101665480B Extraction method of eriosema chinense isoflavoid extract
08/17/2011CN101653565B Traditional Chinese medicament externally applying paste for treating intervertebral disc protrusion
08/17/2011CN101653533B Chinese medicament capable of treating appendicitis, cholecystitis, diseases of fallopian tubes and calculus diseases
08/17/2011CN101647789B Levetiracetam slow release pellet capsule preparation
08/17/2011CN101646416B Composition for external application to skin
08/17/2011CN101643471B C3/C3 fluoroquinolone dimmer derivative using oxadiazole as connection chain as well as preparation method and application thereof
08/17/2011CN101637473B Drug combination containing raloxifene and application thereof
08/17/2011CN101632665B Novel torasemide oral medicine composition
08/17/2011CN101597288B 2-aminoacyl-Beta-3-formyol tryptophan benzyl ester and preparation method and application thereof
08/17/2011CN101596192B Application of palmatine in medicine for treating dengue virus infection
08/17/2011CN101596166B Aspirin enteric-coated pellet
08/17/2011CN101596162B Doxycycline hyclate enteric-coated pellet
08/17/2011CN101591321B Method for preparing 5,6,7,4'-tetrahydroxyflavone
08/17/2011CN101579309B Anti-parasitic ivermectin transdermal solution used for livestock and preparation method thereof
08/17/2011CN101574501B Sanchi and combined spicebush root paste used for preventing and treating cervical spondylosis
08/17/2011CN101559216B Amino acid composition capable of protecting kidney and liver as well as promoting growth for animal and preparation technique thereof
08/17/2011CN101511367B Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent
08/17/2011CN101511365B Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor
08/17/2011CN101503407B Imidazopyridine compound
08/17/2011CN101502506B Medical use of 3-(3,4-dihydroxyphenyl)-acrylic acid 2-(3,4-dihydroxyphenyl)-ethyl ester
08/17/2011CN101497580B HIV-1 inhibitor 2-pyrrolidinone derivative, as well as synthesizing method and use thereof
08/17/2011CN101492475B Tetraphenyl stibium dicarboxylic acid complex, preparation and uses thereof
08/17/2011CN101479279B Penem prodrugs
08/17/2011CN101463062B Compound separated from Gynostemma pentaphylla total saponin acid hydrolysis products
08/17/2011CN101461788B Phloroglucine orally disintegrating tablet and preparation method thereof
08/17/2011CN101455655B Creatine sustained-release preparation and preparation process thereof medication
08/17/2011CN101444549B Composition of plant extracts for preventing or curing metabolism disorder of blood lipid and application thereof
08/17/2011CN101434660B Method for extracting Ganoderma lucidum polysaccharide by ultrasonic wave-microwave combination
08/17/2011CN101422462B Use of ligustrazine phosphate in preparing medicine for treating dilated cardiomyopathy
08/17/2011CN101420931B Solid preparation for oral application
08/17/2011CN101406460B Euthyrox tablet
08/17/2011CN101396460B Preparation method of anti-hemorrhoid extract containing rutin and naringin
08/17/2011CN101347511B Medicament composition with function for reducing blood sugar
08/17/2011CN101323629B 4-{6-[5-(2-chlorinde-6- methylaniline formyl)-thiazole-2-amido]-2-methyl pyrimidine-4}-piperazine-1- diethyl methylphosphate
08/17/2011CN101307052B Method for preparing pyrrole-N-heterocyclic ring derivates and medical application thereof
08/17/2011CN101297841B Compound Tripterygium wilfordii multi-glycosides formulation for curing rheumatic disease and preparation method thereof
08/17/2011CN101279901B Honokiol series derivates, preparation and use thereof
08/17/2011CN101255136B 5-cyclopropane toroid hydantoin derivatives as well as preparation method and uses thereof
08/17/2011CN101250529B Horse infectious anemia virus soluble acceptor, coded sequence and uses thereof
08/17/2011CN101244072B Application of asiaticoside in pulmonary fibrosis resistant delayed period
08/17/2011CN101230059B Bicycle aza alkyl derivative, preparation method and use in medicine thereof
08/17/2011CN101218245B 3-ester prodrugs of ethynylestradiol
08/17/2011CN101190232B Magnesium isoglycyrrhizinate freeze dried powder injection for injection and preparation method thereof
08/17/2011CN101189234B Heterobicyclic inhibitors of HCV
08/17/2011CN101184728B Peptide deformylase (PDF) inhibitors 4
08/17/2011CN101163710B Phosphine transition metal complex, process for producing the same and anticancer drug containing the same
08/17/2011CN101146817B Novel compounds derived from 5-thioxylose and therapeutic use thereof
08/17/2011CN101080395B Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents
08/17/2011CN101056642B Improved photosensitizer formulations and their use
08/17/2011CN101054393B Adefovir dipivoxil anhydrous crystal, preparation method and medicine composition thereof
08/17/2011CN101035789B (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
08/17/2011CN101010296B Piperazine derivatives of alkyhydroxy indole
08/17/2011CN101006992B Propofol freeze-dried emulsion and its preparing method
08/17/2011CN101002772B Nanometer particle targeted preparation of hydroxycamptothecine, and its preparing method
08/16/2011US7999119 Compounds having CRTH2 antagonist activity
08/16/2011US7999117 Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
08/16/2011US7999114 Dicycloalkylcarbamoyl ureas as glucokinase activators
08/16/2011US7999113 Such as 1-(benzo[d][1,3]dioxol-6-yl)-n-(5-((2-chlorophenyl)(3-hydroxypyrrolidin-1-yl)methyl)thiazol-2-yl)cyclopropanecarboxamide; genetic disorders
08/16/2011US7999109 CCR9 inhibitors and methods of use thereof
08/16/2011US7999107 Psychological disorders; cognition activators; Alzheimer's disease; headaches; nervous system antiinflammatory agents; antiepileptic agents; Parkinson's disease; Huntington's disease; schizophrenia; eating disorders
08/16/2011US7999101 Genetic material complexing and internalizing capacity; low cytotoxicity; such as 2-[4-(3-amino-propylamino)-6-tetradecylamino-[1,3,5]triazin-2-ylamino]-ethanethiol or its disulphide dimer
08/16/2011US7999099 Modified 5′-phosphonate azidothymidine—potential anti-viral preparations
08/16/2011US7999090 Fungal cell wall synthesis gene
08/16/2011US7999072 Mutated netrin-4, fragments thereof and their use as medicines
08/16/2011US7999064 Polyquaternium-1 synthesis methods and associated formulations
08/16/2011US7999063 Polyquaternium-1 synthesis methods and associated formulations
08/16/2011US7999011 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics
08/16/2011US7999010 Indene derivatives as pharmaceutical agents
08/16/2011US7999009 Strontium salts of sulphonic acids, a process for their preparation and pharmaceutical compositions containing them
08/16/2011US7999008 Urea compounds that promote desquamation
08/16/2011US7999007 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
08/16/2011US7999006 Anticancer agents; mitogen-activated protein kinases (MEK)
08/16/2011US7999005 Growth stimulant compositions
08/16/2011US7999004 Alpha -tocopherol, hydro-Q9 chromene, coenzyme Q9, cycloartane, 1-Feruloyl glycerol; activates estrogen receptors; improving menopause symptoms
08/16/2011US7999003 Antioxidant compositions and methods thereto
08/16/2011US7999002 Use of N-(dibenz(b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) or a pharmaceutically acceptable addition salt thereof for the prophylaxis and/or treatment of muscular dystrophy
08/16/2011US7999001 Antiviral compounds and methods of using thereof
08/16/2011US7999000 N-(2-amino-phenyl)-acrylamides
08/16/2011US7998999 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
08/16/2011US7998998 Therapeutic substituted lactams
08/16/2011US7998997 Inhibitors of fibroblast activation protein alpha
08/16/2011US7998996 Substituted pyrazoline compounds for reducing triglycerides in blood